Response prediction after 2 cycles of [177Lu]PSMA-I&T radioligand therapy using whole-tumor histogram analysis of baseline PSMA PET
Nuklearmedizin - NuclearMedicine · 01.03.2024 · 63 (02) · 144
DOI: 10.1055/s-0044-1782443 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nuklearmedizin - NuclearMedicine, erschienen am 01.03.2024. Verfasst von F. Kind und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Kind, F., Nemer, U., Jilg, C., Meyer, P. T., Mix, M., & Freitag, M. (2024). Response prediction after 2 cycles of [177Lu]PSMA-I&T radioligand therapy using whole-tumor histogram analysis of baseline PSMA PET. Nuklearmedizin - NuclearMedicine, 63(02), 144. https://doi.org/10.1055/s-0044-1782443
Vancouver
Kind F, Nemer U, Jilg C, Meyer PT, Mix M, Freitag M. Response prediction after 2 cycles of [177Lu]PSMA-I&T radioligand therapy using whole-tumor histogram analysis of baseline PSMA PET. Nuklearmedizin - NuclearMedicine. 2024;63(02):144. doi:10.1055/s-0044-1782443
BibTeX
@article{Kind2024,
author = {Kind, F. and Nemer, U. and Jilg, C. and Meyer, P. T. and Mix, M. and Freitag, M.},
title = {Response prediction after 2 cycles of [177Lu]PSMA-I&T radioligand therapy using whole-tumor histogram analysis of baseline PSMA PET},
journal = {Nuklearmedizin - NuclearMedicine},
year = {2024},
volume = {63},
number = {02},
pages = {144},
doi = {10.1055/s-0044-1782443}
}
EUVIMED